Search

Showing "11155" results for ""

IAS: High risk of death for South Africans in first six months of ART, isoniazid may reduce risk

Tipranavir moves closer to approval in Europe

IAS: WHO clinical staging excluding many without symptoms from HIV treatment, despite need

IAS: Studies in Uganda show generic fixed-dose combinations safe and effective in children with HIV

IAS: Rifampin TB treatment does not reduce response to NNRTIs, South Africans report

IAS: Exercise of benefit for lipodystrophy

IAS: DART trial shows AZT/3TC/tenofovir effective in majority after one year

IAS: Activists and investigators debate future of trials of drug that may prevent HIV

IAS: $7 viral load test equivalent to more expensive high tech viral load tests, Malawi study shows

TB drug resistance on rise in Botswana as HIV epidemic grows

Superinfection with drug-resistant HIV: case reported

Gilead reports problems putting tenofovir, FTC and efavirenz into one pill

Hepatitis A vaccination effective and safe in HIV-positive children

Could valproic acid eradicate HIV from the body?

Large study proves that HAART reduces rates of AIDS and death

High proportion of HIV-positive patients obese or overweight

Race does not affect effectiveness of HAART: US women's study

Ranbaxy says seven ARV products are back on WHO list

Receive the latest HIV research and conference news

Showing "11155" results for ""

IAS: High risk of death for South Africans in first six months of ART, isoniazid may reduce risk

Tipranavir moves closer to approval in Europe

IAS: WHO clinical staging excluding many without symptoms from HIV treatment, despite need

IAS: Studies in Uganda show generic fixed-dose combinations safe and effective in children with HIV

IAS: Rifampin TB treatment does not reduce response to NNRTIs, South Africans report

IAS: Exercise of benefit for lipodystrophy

IAS: DART trial shows AZT/3TC/tenofovir effective in majority after one year

IAS: Activists and investigators debate future of trials of drug that may prevent HIV

IAS: $7 viral load test equivalent to more expensive high tech viral load tests, Malawi study shows

TB drug resistance on rise in Botswana as HIV epidemic grows

Superinfection with drug-resistant HIV: case reported

Gilead reports problems putting tenofovir, FTC and efavirenz into one pill

Hepatitis A vaccination effective and safe in HIV-positive children

Could valproic acid eradicate HIV from the body?

Large study proves that HAART reduces rates of AIDS and death

High proportion of HIV-positive patients obese or overweight

Race does not affect effectiveness of HAART: US women's study

Ranbaxy says seven ARV products are back on WHO list

Receive the latest HIV research and conference news